The global bank worked closely with Execor to build, test, and launch a bespoke customer-facing chatbot that uses the latest.
European healthcare group wanted GCC entry. UAE medical network was perfect target. But emotional sellers, cultural differences, valuation gaps, and transparency concerns threatened the deal. We coordinated between parties, built trust, managed expert due diligence teams, and navigated sensitive negotiations. Deal closed successfully with both buyer and seller achieving strategic goals.
Six consecutive years of losses. Google rating of 2.8. Blacklisted by insurance companies. High staff attrition. This KSA medical centre was months from closure. We deployed AI for patient communications, re-engineered 80% of operations, and recruited key management. Result: Profitable in 8 months, shareholders received dividends for first time in 6 years.
Location Tag: 🇸🇦 Saudi Arabia (KSA)
Prominent UAE healthcare company expanding to Bahrain faced regulatory deadlock—complex traffic flow and parking requirements threatening indefinite delay. We coordinated across municipality, landlord, and traffic agencies to redesign facility access and ensure compliance. Strategic importance recognized: facility inaugurated under patronage of His Royal Highness the Prime Minister.
No regulatory precedent. Heavy financial model. Inadequate infrastructure. A multi-country investor group needed a hospital licensed in a category that didn't exist. We created the licensing framework with government agencies, redesigned the financial model, solved infrastructure challenges, and launched Bahrain's highest-rated hospital—complete with European innovation award.
New multi-specialty medical centre nearing completion faced crisis: 30-month cash flow deficit projection and obsolete operational design threatening viability before opening. We re-engineered the financial model, integrated AI-driven workflow systems, reduced staffing requirements 15%, and cut break-even timeline from 30 months to 12 months. Launched with superior efficiency and competitive advantage.
Investor group evaluating Muscat healthcare market entry faced uncertainty on business model, location, and regulatory pathways. We conducted intensive 3-day market research: stakeholder interviews, site surveys, hospital visits, demand analysis. Evaluated 5 sites and 4 business models. Delivered data-driven clarity enabling confident progression to financial feasibility and business planning.